Enzyme | EC
Number | Gene | Locus | Laboratory |
Aminopeptidases |
Acylaminoacyl-peptidase
(acylamino
amidohydrolase) | EC 3.4.19.1 | AAH1 | At4g14570 | Walling |
Aminopeptidase
N | EC3.4.11.2 | AP-N | At1g63770 | Walling |
Aspartyl
aminopeptidase | EC 3.4.11.7 | DAP1 | At5g60160 | Walling |
| DAP2 | At5g04710 |
Insulin
responsive aminopeptidase
(M1 like aminopeptidase) | EC.3.4.11.7 | APM1 | At4g33090 | A.
Murphy |
Leucyl aminopeptidase | EC
3.4.11.1 | LAP1 | At2g24200 | Walling |
| LAP2* | At4g30920 |
| LAP3* | At4g30910 |
Leukotriene
A4 hydrolase | EC 3.3.2.6 | LKH | At5g13520 | Walling |
Methionine
aminopeptidase | EC 3.4.11.18 | MAP1A | At2g45240 | Bradshaw/Meinnel |
| MAP1B | At1g13270 |
| MAP1C | At3g25740 |
| MAP1D | At4g37040 |
| MAP2A | At2g44180 |
| MAP2B | At3g59990 |
Prolyl
aminopeptidase | EC 3.4.11.5 | PAP1 | At3g61540 | Walling |
| PAP2 | At2g14260 |
Pyroglutamyl
peptidase | EC 3.4.19.3 | PGP1 | At1g56700 | Walling |
| PGP2 | At1g23440 |
Tripeptidyl
peptidase | E.C. 3.4.14.10 | TPP1 | At4g20850 | Walling |
X-Pro
aminopeptidase | EC 3.4.11.9 | AAP1 | At4g36760 | A.
Murphy |
| AAP2 | At3g05350 | Walling |
| AAP3 | At1g09300 |
X-Pro
dipeptidase | EC 3.4.13.9 | XPD | At4g29490 | Walling |
X-Pro
dipeptidyl peptidase | EC 3.4.14.11 | DPP1 | At5g24260 | Walling |
| DPP2 | | J.
Brusslan/Walling |
| |
Transferases |
Arginyl-tRNA
protein transferase | EC
2.3.2.8 | ATE1 | At5g05700 | Walling/Bradshaw |
| ATE2 | At3g11240 | Bradshaw/Walling |
Asparigine
N-terminal amidase
(Asparagine amido hydrolase) | ----- | NTA1 | At2g44420 | Bradshaw/Walling |
Glutamine
cyclotransferase | EC 2.3.2.5 | GCT* | At4g25720 | Bradshaw/Walling |
Methionyl-tRNA
formyltransferase | EC.2.1.2.9 | NFT1 | At1g66520 | Dirk |
N-acetyl
transferases | ---- | NAT1 | At1g80410 | Bradshaw/Walling |
| NAT2* | At5g13780 |
| NAT3* | At1g03150 |
| NAT4 | At2g38130 |
peptide
deformylase | EC 3.5.1.88 | PDF1 | At1g15390 | Dirk |
| PDF2 | At5g14660 |
N-myristoyl
CoA transferase | EC2.3.1.97 | NMT1 | Atg57020 | Bradshaw/Datla |
| NMT2 | At2g44170 |
| |
Community
Resources being developed.
Antisera to all NTMEs and homozygous
KO lines are being identified. A LAP polyclonal antiserum is currently available.
Contact L. Walling (UC Riverside) at linda.walling@ucr.edu.
